Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 108 results found. Search for [ Biocon share ]

Results 1 to 21 of 108
BusinessToday.In
December 3, 2019
Siddharth Mittal has been a core member of Biocon's leadership team since May 2013. He has been serving as the Chief Financial Officer of the company since August 2014


BusinessToday.In
December 3, 2019
Ogivri will be launched at a competitive discount for customers to help ensure increased access to treatment for thousands of HER2-positive breast and gastric cancer patients, said Biocon


BusinessToday.In
December 2, 2019
Reliance Industries stock will remain in focus as RIL is seen as a major beneficiary after Jio announced tariff hike on Sunday.


E Kumar Sharma
New Delhi, November 25, 2019
A number of biologics with huge markets are going off-patent in the US. Do Indian pharmaceutical companies have it in them to play this high-cost, high-risk game of launching biosimilars?


BusinessToday.In
November 5, 2019
Varun Beverages share price has gained 35% since the beginning of this year and risen 38.89% during the last one year


BusinessToday.In
November 5, 2019
After hitting intra day high of Rs 263.70, Biocon stock saw profit-booking and fell 3.11% to Rs 355 on BSE


Goutam Das and Rukmini Rao
New Delhi, October 30, 2019
Whistleblower allegations fall in four buckets - questionable accounting standards; ethics of top management; disclosure standards; and ethnic slur


BusinessToday.In
New Delhi, October 30, 2019
Sixteen CEOs and economists lay out a roadmap to revive the economy


BusinessToday.In
October 11, 2019
Shares of Biocon rose over 4% intraday after the company said that its wholly owned subsidiary Biocon Biologics and Just - Evotec Biologics have entered into a strategic licensing agreement for an early stage, pre-clinical biosimilar asset


E Kumar Sharma
New Delhi, September 17, 2019
Putting India on the global biopharma map


E Kumar Sharma
September 5, 2019
Even as smaller Indian companies are looking to grow their business in the US market, the larger focus is on leading pharma companies because the top 20 of them contribute 75 per cent to total pharma exports from India


Joe C Mathew
New Delhi, August 5, 2019
Lack of competitiveness, paucity of risk capital, infrastructure issues and a strong rupee are preventing exports from taking off


BusinessToday.In
July 25, 2019
Domestic equity benchmarks BSE Sensex and NSE Nifty ended registering minor losses by the closing bell on Thursday, backed by high FII sell-off, along with muted corporate earning numbers, ahead of July F&O expiry.


BusinessToday.In
July 25, 2019
Domestic equity benchmarks BSE Sensex and NSE Nifty ended registering minor losses by the closing bell on Thursday, backed by high FII sell-off, along with muted corporate earning numbers, ahead of July F&O expiry.\"The recent decline is reflecting participants' disappointment to the earnings season so far. Markets were already struggling with a lot of domestic and global issues and lack of support from the earnings front has further deteriorated the sentiment,\" quoted Ajit Mishra Vice P...


BusinessToday.In
June 14, 2019
Equity benchmark indices extended losses in the last hour of the trade to end in the red, after sources said that India will impose retaliatory tariffs on 29 US products.Sensex ended down by 289.29 points at 38,452, while Nifty fell by 90.75 points to close at 11,823. Overall 26 out of the 30 stocks ended in the red on Sensex and 42 out of the 50 stocks were negative on Nifty.On the sectoral front, all indices closed in the red. Media and Realty were the biggest losers and wer...


BusinessToday.In
May 9, 2019
 Indian equity market extended losses for the seventh consecutive session on Thursday led by decline in Power, Pharma, Energy indices. Escalated trade tensions between China and the US also prompted investors to remain cautious throughout the trading session.


BusinessToday.In
April 26, 2019
Market Live Updates: Tata Steel, Axis Bank, BPCL, GHCL, GAIL, ICICI Bank are among the top gainers in the closing session.


PTI
New Delhi, April 25, 2019
For the full 2018-19 fiscal, the MCX posted 35 per cent increase in its net profit at Rs 146.24 crore, as compared with Rs 108.36 crore in the previous financial year


PTI
New Delhi, April 25, 2019
For the fiscal year ended March 2019, Biocon net profit rose over two fold to Rs 905.3 crore as against Rs 372.4 crore for 2017-18


PTI
April 25, 2019



PAGES 1 OF 6  12345